This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.52 delivery order contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a period of performance through January 16, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,484.70 for the supply of budesonide-formoterol 160-4.5 10.2GM medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 2024. The contract type is firm fixed price. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,709.60 with a Firm Fixed Price pricing type. The award is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,760.00, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,331.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with an ultimate completion date of October 7, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $4,506.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a period of performance through May 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $2,362.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of July 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,483.32, is a delivery order for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,313.40, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...